| Retroviral superinfection resistance. |
Nethe M, Berkhout B, van der Kuyl AC |
2005 |
| Aggressive HIV-1? |
Berkhout B, de Ronde A, van der Hoek L |
2005 |
| A historical reflection on the discovery of human retroviruses. |
Vahlne A |
2009 |
| The mutation T477A in HIV-1 reverse transcriptase (RT) restores normal proteolytic processing of RT in virus with Gag-Pol mutated in the p51-RNH cleavage site. |
Abram ME, Sarafianos SG, Parniak MA |
2010 |
| It's the virus, stupid--part 2. |
Berkhout B |
2005 |
| A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants. |
Johnson BC, Pauly GT, Rai G, Patel D, Bauman JD, Baker HL, Das K, Schneider JP, Maloney DJ, Arnold E, Thomas CJ, Hughes SH |
2012 |
| Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance. |
Xu HT, Martinez-Cajas JL, Ntemgwa ML, Coutsinos D, Frankel FA, Brenner BG, Wainberg MA |
2009 |
| Comparative biochemical analysis of recombinant reverse transcriptase enzymes of HIV-1 subtype B and subtype C. |
Xu HT, Quan Y, Asahchop EL, Oliveira M, Moisi D, Wainberg MA |
2010 |
| Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection. |
van Marle G, Church DL, Nunweiler KD, Cannon K, Wainberg MA, Gill MJ |
2010 |
| Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA. |
Michailidis E, Ryan EM, Hachiya A, Kirby KA, Marchand B, Leslie MD, Huber AD, Ong YT, Jackson JC, Singh K, Kodama EN, Mitsuya H, Parniak MA, Sarafianos SG |
2013 |
| Evolving uses of oral reverse transcriptase inhibitors in the HIV-1 epidemic: from treatment to prevention. |
Gupta RK, Van de Vijver DA, Manicklal S, Wainberg MA |
2013 |